The Story of the Silent Killer : A History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debates
- PMID: 32852612
- DOI: 10.1007/s11906-020-01077-7
The Story of the Silent Killer : A History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debates
Abstract
Hypertension is the leading risk factor for death and disability-adjusted life-years lost globally. Despite this tremendous impact on health, blood pressure measurement and treatment are relatively new to medical practice, with widespread measurement beginning just over 100 years ago. How, in such a short time, did blood pressure become such an integral measurement in medical practice that it is now considered one of the vital signs? Key revelations through Stephen Hales and his horse experiment, Riva-Rocci's modern blood pressure cuff, Korotkoff sounds, and President Roosevelt's death set the stage for discovery. Landmark trials such as the VA Cooperative studies of the 1960s through the recent Systolic Blood Pressure Intervention Trial and Prevention with Mediterranean Diet trials provide the foundation for modern clinical practice. An understanding of the history of hypertension can directly affect current clinical practice and offers unique insights into how the medical community has approached the management of one of the deadliest medical conditions in history.
Keywords: Antihypertensive medication development; Blood pressure goals; Hypertension history; Hypertension trials; Korotkoff; Oscillometry; Sphygmomanometer.
Comment in
-
Comments on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate.Curr Hypertens Rep. 2021 Feb 3;23(2):6. doi: 10.1007/s11906-020-01122-5. Curr Hypertens Rep. 2021. PMID: 33537854 No abstract available.
-
Response to "Comment's on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate".Curr Hypertens Rep. 2021 Feb 3;23(2):7. doi: 10.1007/s11906-020-01123-4. Curr Hypertens Rep. 2021. PMID: 33537893 No abstract available.
Similar articles
-
[Riva-Rocci and blood pressure].Ned Tijdschr Geneeskd. 2013;157(3):A5536. Ned Tijdschr Geneeskd. 2013. PMID: 23328024 Dutch.
-
From Concept to Cure: The Life and Legacy of Scipione Riva-Rocci.Cureus. 2024 Sep 29;16(9):e70436. doi: 10.7759/cureus.70436. eCollection 2024 Sep. Cureus. 2024. PMID: 39473675 Free PMC article. Review.
-
Reintroduction of Riva-Rocci measurements to determine systolic blood pressure?Neth J Med. 2008 Dec;66(11):480-2. Neth J Med. 2008. PMID: 19075314
-
Scipione Riva-Rocci and the men behind the mercury sphygmomanometer.Int J Clin Pract. 2006 Jan;60(1):73-9. doi: 10.1111/j.1742-1241.2005.00548.x. Int J Clin Pract. 2006. PMID: 16409431
-
Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.Blood Press Monit. 1999 Dec;4(6):319-31. doi: 10.1097/00126097-199912000-00005. Blood Press Monit. 1999. PMID: 10602536 Review.
Cited by
-
Estimation of Physiologic Pressures: Invasive and Non-Invasive Techniques, AI Models, and Future Perspectives.Sensors (Basel). 2023 Jun 20;23(12):5744. doi: 10.3390/s23125744. Sensors (Basel). 2023. PMID: 37420919 Free PMC article. Review.
-
Importance of Considering Temporal Variations in Pulse Wave Velocity for Accurate Blood Pressure Prediction.Ann Biomed Eng. 2025 May;53(5):1080-1094. doi: 10.1007/s10439-025-03681-7. Epub 2025 Feb 6. Ann Biomed Eng. 2025. PMID: 39912848 Free PMC article.
-
Detection and categorization of severe cardiac disorders based solely on heart period measurements.Sci Rep. 2022 Oct 11;12(1):17019. doi: 10.1038/s41598-022-21260-x. Sci Rep. 2022. PMID: 36221030 Free PMC article.
-
Commonalities and differences in carotid body dysfunction in hypertension and heart failure.J Physiol. 2023 Dec;601(24):5527-5551. doi: 10.1113/JP284114. Epub 2023 Sep 25. J Physiol. 2023. PMID: 37747109 Free PMC article.
-
A Study on Types of Medication Adherence in Hypertension among Older Patients and Influencing Factors.Healthcare (Basel). 2022 Nov 20;10(11):2322. doi: 10.3390/healthcare10112322. Healthcare (Basel). 2022. PMID: 36421646 Free PMC article.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94.
-
- Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm hg, 1990-2015. JAMA. 2017;317(2):165–82. - PubMed
-
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389:37–55.
-
- Constant AF, Geladari EV, Geladari CV. The economic burden of hypertension. Chapter 21. In: Andreadis EA, editor. Hypertension and cardiovascular disease. Switzerland: Springer International Publishing; 2016.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical